CATHERINE WHELIN COSTEN INVITES WEST COAST TMS’ DR STEIN TO SHARE HER EXPERTISE ON TMS AND MOOD DISORDERS WITH THE PUBLIC
West Coast TMS Institute‘s director Kira Stein, MD discusses how transcranial magnetic stimulation, or TMS, is an effective, non-invasive, FDA-approved, office-based treatment for clinical depression with few side effects. She explains how major depressive disorder, also known as “clinical depression”, is diagnosed and how it is different from everyday sadness. Also addressed are the issues of suicide, postpartum depression, and how TMS fits into the depression treatment algorithm along with other potential treatments, such as psychotherapy, antidepressant medications, ECT (electroconvulsive therapy), VNS, and deep brain stimulation. Hope for depression sufferers is emphasized, as so many new treatments for depression, like TMS, exist, and so many newer ones will soon become available over the next few years.
Kira Stein, MD
West Coast TMS Director
Dr. Kira Stein is a clinical instructor at UCLA’s Psychiatry Department at the UCLA David Geffen School of Medicine, and is certified in the clinical use of TMS, as well as has completed intensive coursework on TMS at Harvard’s Berenson-Allen Center for Non-Invasive Brain Stimulation and a Visiting Fellowship at Duke University.”15% of people who suffer from major depressive disorder do not benefit sufficiently from talk therapy and medications,” states Dr. Stein. “TMS is a safe and outpatient non-drug treatment for depression that is effective and should be considered as another option before trying another medication. TMS has a less side effects than medications and is comparably quite effective. We have seen a great success rate here at West Coast TMS, especially with our unique integrative and comprehensive approach.”
